These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28418172)

  • 1. Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain.
    Schliessbach J; Vuilleumier PH; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2017 Sep; 21(8):1336-1345. PubMed ID: 28418172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug efficacy in chronic low back pain by quantitative sensory tests.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Stamer U; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2018 May; 22(5):973-988. PubMed ID: 29363217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
    Siegenthaler A; Schliessbach J; Vuilleumier PH; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    BMC Pharmacol Toxicol; 2015 Sep; 16():23. PubMed ID: 26376691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers.
    Besson M; Matthey A; Daali Y; Poncet A; Vuillemier P; Curatolo M; Zeilhofer HU; Desmeules J
    Pain; 2015 Mar; 156(3):397-404. PubMed ID: 25687539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Arendt-Nielsen L; Curatolo M
    Scand J Pain; 2017 Oct; 17():107-115. PubMed ID: 28850362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of single-dose imipramine on chronic low-back and experimental pain. A randomized controlled trial.
    Schliessbach J; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Vuilleumier PH; Stamer U; Arendt-Nielsen L; Curatolo M
    PLoS One; 2018; 13(5):e0195776. PubMed ID: 29742109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: a crossover, randomised, double-blinded, placebo-controlled study.
    Wetzel L; Zadrazil M; Paternostro-Sluga T; Authried G; Kozek-Langenecker S; Scharbert G
    Eur J Anaesthesiol; 2014 Jan; 31(1):35-40. PubMed ID: 24141646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
    Lee JH; Lee CS;
    Clin Ther; 2013 Nov; 35(11):1830-40. PubMed ID: 24183364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study.
    Vuilleumier PH; Besson M; Desmeules J; Arendt-Nielsen L; Curatolo M
    PLoS One; 2013; 8(3):e43896. PubMed ID: 23554851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic study.
    Besson M; Daali Y; Di Lio A; Dayer P; Zeilhofer HU; Desmeules J
    Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):192-7. PubMed ID: 23006671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients.
    Neziri AY; Dickenmann M; Scaramozzino P; Andersen OK; Arendt-Nielsen L; Dickenson AH; Curatolo M
    Pain; 2012 Feb; 153(2):311-318. PubMed ID: 22100357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect.
    Edwards RR; Dolman AJ; Michna E; Katz JN; Nedeljkovic SS; Janfaza D; Isaac Z; Martel MO; Jamison RN; Wasan AD
    Pain Med; 2016 Oct; 17(10):1882-1891. PubMed ID: 26933094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain.
    Katz J; Pennella-Vaughan J; Hetzel RD; Kanazi GE; Dworkin RH
    J Pain; 2005 Oct; 6(10):656-61. PubMed ID: 16202958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain.
    Rauck RL; Potts J; Xiang Q; Tzanis E; Finn A
    Postgrad Med; 2016 Jan; 128(1):1-11. PubMed ID: 26634956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.
    Kivitz AJ; Gimbel JS; Bramson C; Nemeth MA; Keller DS; Brown MT; West CR; Verburg KM
    Pain; 2013 Jul; 154(7):1009-21. PubMed ID: 23628600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers.
    Matthey A; Daali Y; Curtin F; Poncet A; Desmeules J; Besson M
    Eur J Pain; 2020 Jul; 24(6):1094-1106. PubMed ID: 32171038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, active-controlled trial of fluoroscopic lumbar interlaminar epidural injections in chronic axial or discogenic low back pain: results of 2-year follow-up.
    Manchikanti L; Cash KA; McManus CD; Pampati V; Benyamin RM
    Pain Physician; 2013; 16(5):E491-504. PubMed ID: 24077199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term, prolonged-release oral tapentadol for the treatment of refractory chronic low back pain: a single-center, observational study.
    Finco G; Mura P; Musu M; Deidda C; Saba M; Demelas I; Evangelista M; Sardo S
    Minerva Med; 2018 Aug; 109(4):259-265. PubMed ID: 29947490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study.
    Uberall MA; Mueller-Schwefe GH; Terhaag B
    Curr Med Res Opin; 2012 Oct; 28(10):1617-34. PubMed ID: 22970658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.